BREAKING
NGX All-Share Index gains 412 points — MTN, Zenith, GTCo top movers CBN holds MPR at 27.5% — rate cuts possible Q3 2026 Dangote Refinery begins export of refined petroleum products SEC Nigeria approves new digital assets trading framework NGX All-Share Index gains 412 points — MTN, Zenith, GTCo top movers CBN holds MPR at 27.5% — rate cuts possible Q3 2026
LIVE
NGX 104,562 ▲0.42% | USD/NGN ₦1,614 ▼0.12% | BTC $84,210 ▲1.24% | DANGCEM ₦412 ▲1.10% | GTCO ₦58.45 ▲0.77% | MTNN ₦224.80 ▼0.31% | ZENITH ₦42.15 ▲0.60% | NGX 104,562 ▲0.42% | USD/NGN ₦1,614 ▼0.12% | BTC $84,210 ▲1.24%
₦90K
Weekly Giveaway — 5 Winners Every Week
1st: ₦50K  |  2nd–5th: ₦10K each  |  Be active to win
1,103Members
19,706Threads
26,424Posts
JOIN NOW
NGX
Live

Coronavirus: WHO suspends trials of drug that Trump is taking over safety fears.

  • Weekly Giveaway for our active users. N50,000 per Week. Do you want to contribute to this community? We are looking for contribution? What is hot right now? Sign up and get in on the ground floor of the newest, fastest growing Nigerian forum!
M

Melvin

Active Member
Apr 24, 2020
548
96
28
cwry.se
WEBSITE
https://cwry.se/@melvinyoungharry
YAHOO
Obelem53@yahoo.com
World Health Organisation is removing hydroxychloroquine from its global study of potential coronavirus treatments while it carries out a review of its safety.Last week, Donald Trump said he was taking the anti-malarial drug, which he has promoted as providing possible protection from the coronavirus, despite warnings from health officials that it could cause heart problems.The decision by the WHO to temporarily suspend hydroxychloroquine from its study last week which suggested it might actually increase risk for COVID-19 patients.
 
You must log in or register to reply here.
Top Bottom
Back